Upgrade to SI Premium - Free Trial

Tarsus Pharmaceuticals to acquire Alkeus for up to $800M

August 6, 2026 7:01 AM
Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) announced a definitive agreement to acquire Alkeus Pharmaceuticals, Inc., a privately held biotechnology company developing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Mergers and Acquisitions